BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37460542)

  • 21. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis.
    Shi Y; Gong M; Deng Z; Liu H; Chang Y; Yang Z; Cai L
    Biochem Biophys Res Commun; 2021 Aug; 567():118-124. PubMed ID: 34147710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
    Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA
    J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incorporation of cystine by the soluble carrier family 7 member 11 (SLC7A11) is a component of the redox regulatory mechanism in stallion spermatozoa†.
    Ortiz-Rodriguez JM; Martín-Cano FE; Ortega-Ferrusola C; Masot J; Redondo E; Gázquez A; Gil MC; Aparicio IM; Rojo-Domínguez P; Tapia JA; Rodriguez-Martínez H; Peña FJ
    Biol Reprod; 2019 Jul; 101(1):208-222. PubMed ID: 30998234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
    Pham AN; Blower PE; Alvarado O; Ravula R; Gout PW; Huang Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):949-58. PubMed ID: 20007406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia.
    Wang H; Lu J; Alencastro F; Roberts A; Fiedor J; Carroll P; Eisenman RN; Ranganathan S; Torbenson M; Duncan AW; Prochownik EV
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1785-1804. PubMed ID: 35259493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
    Huang F; Huang Z; Wei Q; Liu G; Pu J
    Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.
    Billin AN; Eilers AL; Coulter KL; Logan JS; Ayer DE
    Mol Cell Biol; 2000 Dec; 20(23):8845-54. PubMed ID: 11073985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis as a p53-mediated activity during tumour suppression.
    Jiang L; Kon N; Li T; Wang SJ; Su T; Hibshoosh H; Baer R; Gu W
    Nature; 2015 Apr; 520(7545):57-62. PubMed ID: 25799988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
    Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
    He J; Wang X; Chen K; Zhang M; Wang J
    Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11.
    Martin L; Gardner LB
    Oncogene; 2015 Aug; 34(32):4211-8. PubMed ID: 25399695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
    Liu J; Xia X; Huang P
    Mol Ther; 2020 Nov; 28(11):2358-2366. PubMed ID: 32931751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
    Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
    Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.
    Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W
    Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
    Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
    Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway.
    Liu Z; Wang X; Li J; Yang X; Huang J; Ji C; Li X; Li L; Zhou J; Hu Y
    Chem Biol Interact; 2023 Sep; 382():110602. PubMed ID: 37302459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.